Third course of Lemtrada improves MS patient’s relapse rate

A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Third course of Lemtrada improves MS patient’s relapse rate

Post by MSUK » Mon Mar 05, 2018 8:27 am

Study shows third course of Lemtrada improves MS patient’s relapse rate and disability

A study released at #ACTRIMS2018 has revealed that patients who experienced relapses after two courses of Lemtrada (alemtuzumab) showed improvement in relapse rate and disability progression after a third course of the drug…Read more - http://www.ms-uk.org/study-shows-third- ... disability

Image
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post